معرفی
Dr. Michael A. Johnson is an Associate Professor in the Department of Chemistry at the University of Kansas. He holds a B.S. from the United States Air Force Academy (1988), an M.S. from the University of Colorado Denver (2000), and a Ph.D. from the University of Virginia (2002). He completed postdoctoral training at the University of North Carolina at Chapel Hill (2002–2005). His research focuses on developing bioanalytical techniques to study neurotransmitter signaling in neurological disorders, including Huntington’s disease, Alzheimer’s disease, and chemobrain.
Key research areas include microsensor development, microfluidics, electrochemical detection, and fluorescence microscopy. Notable projects involve studying dopamine release impairments in neurodegenerative models and chemotherapy-induced cognitive decline. Dr. Johnson’s lab employs cutting-edge methods such as fast-scan cyclic voltammetry and caged compound photolysis to investigate neurotransmitter interactions and oxidative stress mechanisms.
- Selected Awards: ACS Editor’s Choice Award (2016), Featured on ACS Chem. Neurosci. cover (2016)
- Lab Team: Includes PhD candidates Piyanka Hettiarachchi, Ashley Litton, Chase Stucky, and undergraduate researchers Alex Arntt and Elise Campbell
- Key Publications: 2024 study on dopamine uptake modulation, 2023 work on Alzheimer’s and serotonin release, and 2021 analysis of caged compound photochemistry
Current projects explore mechanisms of drug action, Parkinson’s disease modeling, and microfluidic device applications for neurotransmitter analysis.
